E-ISSN: 1308-5263
Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report [Turk J Hematol]
Turk J Hematol. 2024; 41(3): 202-204 | DOI: 10.4274/tjh.galenos.2024.2024.0044

Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report

Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo Zhang
The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China

Keywords: Mixed-phenotype acute leukemia, Targeted therapy, Inotuzumab ozogamicin

Mikst Fenotip Akut Lösemi Tedavisinde Kalikamisin-Inotuzumab Ozogamisin ile Kombine Venetoclax + Azasitidin Rejimi: Olgu Sunumu

Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo Zhang
The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China

Anahtar Kelimeler: Mikst fenotip akut lösemi, Hedefe yönelik tedavi, İnotuzumab ozogamisin

Corresponding Author: Kongfei Li
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE